TechCrunchJudge Rules CRISPR-Cas9 Belongs to Broad Institute | Crunch ReportTechCrunchVerizon is reportedly getting a $250 million discount on its Yahoo deal, judge rules CRISPR-Cas9 belongs to the Broad Institute and not UC Berkeley, Pixar teaches the… Continue reading
Los Angeles Times |
UC Berkeley loses epic fight over patent for CRISPR gene-editing technique
Los Angeles Times The scientists who first harnessed the powerful gene-editing technology known as CRISPR suffered a major defeat Wednesday in their long-running quest to control the rights to their invention. UC Berkeley biochemist Jennifer Doudna and her European … Stop Freaking Out About CRISPR! (Except For One Thing)Forbes Here’s Why Today’s Decision On Who Invented CRISPR MattersGizmodo Broad Institute scientist prevails in epic patent fight over CRISPRWashington Post NPR –TechCrunch –Science Magazine –UC Berkeley News – University of California, Berkeley all 58 news articles » |
TechCrunch |
Crunch Report | Judge Rules CRISPR-Cas9 Belongs to Broad Institute
TechCrunch I don’t know what to wear on Crunch Report (It’s a hard decision and I suck at dressing myself). If you are a startup and want to me to wear something mail me an XL T-shirt and I’ll wear it in an episode. I’m not going to mention the company on the … |
Endpoints News |
UPDATED: Patent board tells CRISPR scientists to back off from a nasty fight over gene editing tech
Endpoints News Berkeley has fought hard to establish preeminent control of CRISPR, the faster, easier way to do gene editing which has been spreading like wildfire at academic groups and startups. Berkeley’s Jennifer Doudna and Emmanuelle Charpentier have been … |
|
Jury’s out on composite floor test in TN
The New Indian Express With the controversy surrounding the current impasse in State yet to abate, the suggestions of Attorney General Mukul Rohatgi to call for a composite floor test to end the deadlock ran into controversy. Here’s what it is all about. When was the … |
Washington Business Journal |
Rockville gene therapy company to begin trials for treatment for leading cause of blindness
Washington Business Journal Rockville-based RegenxBio Inc. has received Food and Drug Administration approval to begin clinical trials of its gene therapy to treat wet age-related macular degeneration, a leading cause of blindness. RegenxBio’s gene therapy technology introduces … |
Washington Business Journal |
Rockville gene therapy company to begin trials for treatment for leading cause of blindness
Washington Business Journal Rockville-based RegenxBio Inc. has received Food and Drug Administration approval to begin clinical trials of its gene therapy to treat wet age-related macular degeneration, a leading cause of blindness. RegenxBio’s gene therapy technology introduces … |
STAT |
An irreverent guide to winners and losers in the CRISPR patent fight
STAT That’s grim news for their cross-country rival, the University of California, where equally acclaimed biochemist Jennifer Doudna first figured out how to use CRISPR to edit DNA (but not in live cells). The biggest winner of the day is clearly the Broad … UC Berkeley suffers big loss in CRISPR patent fight: What’s next for the powerful gene-editing technology?Los Angeles Times How the battle lines over CRISPR were drawnScience Magazine Why the CRISPR patent verdict isn’t the end of the storyNature.com Washington Post –Forbes –Gizmodo –Berkeley News – University of California, Berkeley all 149 news articles » |